Castleview Partners, LLC
- SEC CIK
- 0001737088
- Latest filing
- Jul 20, 2026
NVS holding history
Novartis AG in every 13F filed by Castleview Partners, LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
NVS overviewAll 13F holders of NVSFull Q2 2026 holdings
- Shares (Q3 2024)
- 0
- Sold out in Q3 2024
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 11
- Since Q2 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q3 2024 | 0 | $0 | 0.0% | −77−100.0% | Sold out | Holders |
| Q2 2024 | 77 | $8.20K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2024 | 77 | $7.45K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2023 | 77 | $7.78K | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2023 | 77 | $7.84K | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2023 | 77 | $7.77K | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2023 | 77 | $7.08K | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2022 | 77 | $6.99K | <0.1% | −100−56.5% | Reduced | Holders |
| Q3 2022 | 177 | $13.0K | <0.1% | +37+26.4% | Added | Holders |
| Q2 2022 | 140 | $102 | <0.1% | −887−86.4% | Reduced | Holders |
| Q1 2022 | 1,027 | $90.0K | 0.1% | +1,027 | New | Holders |
| Q3 2021 | – | – | – | – | Not filed | Holders |
| Q2 2021 | 850 | $78.0K | <0.1% | – | No prior filing | Holders |